ANNEX IISupplementary provisions
ANNEX II In Part D of the Annex to Implementing Regulation (EU) No 540/2011, the following entry is added: Number Common Name, Identification Numbers IUPAC Name Purity ( *1 ) Date of approval Expiration of approval Specific provisions ‘3 Cerevisane (no ISO name adopted) CAS No: not allocated CIPAC No: 980 Not relevant ≥ 924 g/kg 23 April 2015 23 April 2030 For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on cerevisane, and in particular Appendices I and II thereof, shall be taken into account.’ ( *1 ) Further details on identity and specification of active substance are provided in the review report.